MARKET

PBE

PBE

Invesco Dynamic Biotech & Genome ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

50.38
+0.23
+0.47%
Closed 16:00 09/20 EDT
OPEN
49.98
PREV CLOSE
50.15
HIGH
50.50
LOW
49.98
VOLUME
5.75K
TURNOVER
--
52 WEEK HIGH
59.76
52 WEEK LOW
43.17
TOTAL ASSET
241.54M
YTD YIELD
6.05%
1D
5D
1M
3M
1Y
5Y

Tools for In-Depth Analysis of PBE, Buy or Sell Stocks and ETFs Commission-Free!

Open a Webull account and fund it to get a free stock

PBE News

  • M&A Activity A Favored Prescription For Biopharmaceutical Companies
  • Seeking Alpha - Article.07/02 10:37
  • Mid-Year Market GPS: Disruptive Forces
  • Seeking Alpha - Article.06/21 15:35
  • Biotech outperforms on M&A animal spirits
  • Seeking Alpha - Article.06/17 17:21
  • Notes From The Road: An Equity Investor's Lens On China
  • Seeking Alpha - Article.06/13 07:48

More

Profile

Fund Name
Invesco Dynamic Biotech & Genome ETF
Risk
Medium-high risk
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD*100.0%
Advisor Company
Invesco
Custodian
The Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon

Asset Allocation

238.93M
  • 99.9180%
  • 0.00%
  • 0.0820%
  • 0.00%

2019 Q2

238.93M

2019 Q1

278.09M

2018 Q4

247.94M

2018 Q3

320.46M

2018 Q2

253.32M

Dividend History

Ex-Div Date
Dividend Per Share
09/24/2018
0.0021
06/16/2017
0.2153
03/17/2017
0.0555
12/16/2016
0.1208
09/16/2016
0.0283
More